new glp 1 agonist novo nordisk Nordisk's weight-loss pill wins FDA approval Novo Nordisk files for FDA

What youll learn: Most GLP-1 receptor agonist medications are taken as daily or weekly injections

In general, DPP-4 inhibitors are effective at promoting moderate lowering of A1C and are associated with few adverse events

2 In the full study population, breast cancer was diagnosed in 1.62% (247/15,264) of women with GLP-1 exposure compared with 2.47% (2,381/96,382) of women without exposure, corresponding to an odds ratio (OR) of 0.649 (95% CI, 0.5690.741

Which class of NSAID do you see most often prescribed in your practice and why

Children 12 or older can take it if they are at or above the 95th weight percentile for their sex and age